626209-17-4 Usage
Uses
Used in Pharmaceutical Industry:
2-BROMO-N-PHENETHYL-PROPIONAMIDE is used as a promising anti-cancer agent for its potential to target and inhibit the growth of cancer cells. Its specific molecular structure allows it to interact with cellular mechanisms in ways that can lead to the suppression of tumor development and progression.
Used in Respiratory Applications:
In the field of respiratory medicine, 2-BROMO-N-PHENETHYL-PROPIONAMIDE can be prepared for bronchodilating activity, which helps to relax and widen the airways. This makes it a potential candidate for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), where improved airway function is crucial for managing symptoms and enhancing patients' quality of life.
Used in Antibacterial Applications:
2-BROMO-N-PHENETHYL-PROPIONAMIDE also exhibits antibacterial activity, making it a potential agent in the development of new antibiotics. Given the growing concern over antibiotic resistance, the discovery and development of new compounds with antibacterial properties are essential for combating resistant bacterial strains and treating infections effectively.
Check Digit Verification of cas no
The CAS Registry Mumber 626209-17-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,6,2,0 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 626209-17:
(8*6)+(7*2)+(6*6)+(5*2)+(4*0)+(3*9)+(2*1)+(1*7)=144
144 % 10 = 4
So 626209-17-4 is a valid CAS Registry Number.
626209-17-4Relevant academic research and scientific papers
Design and synthesis of new 8-anilide theophylline derivatives as bronchodilators and antibacterial agents
Hayallah, Alaa M.,Talhouni, Ahmad A.,Abdel Alim, Abdel Alim M.
, p. 1355 - 1368 (2013/01/15)
Theophylline derivatives have long been recognized as potent bronchodilators for the relief of acute asthma. Recently, it was found that bacterial infection has a role in asthma pathogenesis. The present work involves the design and synthesis of 8-substituted theophylline derivatives as bronchodilators and antibacterial agents. The chemical structures of these compounds were elucidated by IR, 1H-NMR, mass spectrometry, and elemental analyses. The bronchodilator activity was evaluated using acetylcholine-induced bronchospasm in guinea pigs, and most of the compounds showed significant anti-bronchoconstrictive activity in comparison with standard aminophylline. In addition, the antibacterial activity of all the target compounds was investigated in vitro against Gram-positive and Gram-negative bacteria using ampicillin as a reference drug. Results showed that some of the tested compounds possessed significant antibacterial activity. A pharmacophore model was computed to obtain useful insight into the essential structural features of bronchodilator activity. A structure activity relationship was also discussed.
